Britain's medicines regulator said on Friday it had extended approval of the COVID-19 vaccine developed by Pfizer (PFE.N) and BioNTech (22UAy.DE) so it can be used on 12- to 15-year-olds.
Published 4 years ago on Jun 5th 2021, 6:33 am
By Web Desk
"We have carefully reviewed clinical trial data in children aged 12 to 15 years and have concluded that the Pfizer/BioNTech COVID-19 vaccine is safe and effective in this age group and that the benefits of this vaccine outweigh any risk," June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency, said.
She added that it would be up to the Joint Committee on Vaccination and Immunisation to decide whether this age group would come under the vaccine deployment programme.
Courtesy: Reuters
U.S. loss to South Korea another misstep with World Cup prep time running out
- 19 hours ago
Let’s be honest about Charlie Kirk’s life — and death
- 5 hours ago
President expresses Pakistan’s full support for China’s vision of civilisation exchange, mutual learning
- 19 hours ago
Bottom 10: The spitting distance between Florida and Arizona State
- 6 hours ago
Another person dies of Naegleria in Karachi
- 15 hours ago
Apple is giving iPhone 14 and 15 users another free year of satellite features
- 7 hours ago
Wasim Akram tells Pakistan, India to forget noise and ‘enjoy’ Asia Cup clash
- 20 hours ago
Judiciary is facing challenges in journey to deliver justice: CJP Afridi
- 20 hours ago
Nepal returns to calm as first woman PM takes charge, visits wounded
- 15 hours ago
Arab, Muslim leaders to meet in Qatar to denounce Israeli attack
- 16 hours ago
Rally Arcade Classics gets manual transmission option in latest update
- 6 hours ago
PM suspends collection of power bills from consumers in flood-affected areas
- 15 hours ago
You May Like
Trending
